HCW Biologics Inc.(HCWB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HCWB HCW Biologics Inc.

Not Yet Opened 06-02 16:00:00 EDT

1.79

-0.28

-13.53%

盘后1.80

+0.01+0.56%

19:59 EDT

High2.06	Low1.77	Vol1.73M
Open2.06	D1 Closing2.07	Amplitude14.06%
Mkt Cap12.82M	Tradable Cap5.16M	Total Shares7.16M
T/O3.24M	T/O Rate59.99%	Tradable Shares2.88M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"HCWB","market":"US","secType":"STK","nameCN":"HCW Biologics Inc.","latestPrice":1.79,"timestamp":1780430400000,"preClose":2.07,"halted":0,"volume":1729559,"hourTrading":{"tag":"盘后","latestPrice":1.8,"preClose":1.79,"latestTime":"19:59 EDT","volume":41933,"amount":75773.4459,"timestamp":1780444799864,"change":0.01,"changeRate":0.005587,"amplitude":0.027933},"delay":0,"changeRate":-0.1352657004830917,"floatShares":2883200,"shares":7161200,"eps":-9.4538,"marketStatus":"Not Yet Opened","change":-0.28,"latestTime":"06-02 16:00:00 EDT","open":2.06,"high":2.06,"low":1.769,"amount":3240718.4561427003,"amplitude":0.14058,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-9.4538,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780473600000},"marketStatusCode":0,"adr":0,"listingDate":1626753600000,"exchange":"NASDAQ","adjPreClose":2.07,"preHourTrading":{"tag":"盘前","latestPrice":2.05,"preClose":2.07,"latestTime":"09:27 EDT","volume":58294,"amount":119437.7779722,"timestamp":1780406821438,"change":-0.02,"changeRate":-0.009662,"amplitude":0.05314},"postHourTrading":{"tag":"盘后","latestPrice":1.8,"preClose":1.79,"latestTime":"19:59 EDT","volume":41933,"amount":75773.4459,"timestamp":1780444799864,"change":0.01,"changeRate":0.005587,"amplitude":0.027933},"volumeRatio":0.543222},"requestUrl":"/m/hq/s/HCWB/tweets","defaultTab":"tweets","newsList":[{"id":"2640951663","title":"HCW Biologics Wins Nasdaq Extension to Avoid Delisting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640951663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640951663?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:11","pubTimestamp":1780315906,"startTime":"0","endTime":"0","summary":"HCW Biologics ( ($HCWB) ) just unveiled an announcement. HCW Biologics Inc. disclosed that on March 26, 2026, it received notice from Nasdaq that i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hcw-biologics-wins-nasdaq-extension-to-avoid-delisting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hcw-biologics-wins-nasdaq-extension-to-avoid-delisting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NQmain","BK4539","HCWB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640956254","title":"HCW Biologics gets Nasdaq extension to regain $1 minimum bid compliance by July 29","url":"https://stock-news.laohu8.com/highlight/detail?id=2640956254","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640956254?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:32","pubTimestamp":1780313554,"startTime":"0","endTime":"0","summary":"HCW Biologics received a Nasdaq notice for failing to maintain a $1 minimum bid price for 30 consecutive business days under Listing Rule 5550.Nasdaq’s hearings panel granted an extension to regain compliance, requiring a bid price of at least $1 for 20 consecutive trading days by July 29, 2026.Any renewed bid-price deficiency before Sept. 22, 2026 triggers immediate delisting.Any other listing-rule breach before Sept. 22, 2026 requires a cure plan within seven days, subject to panel approval.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCW Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchang","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL92bHvb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HCWB","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639613378","title":"HCW Biologics Is Maintained at Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2639613378","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639613378?lang=en_us&edition=fundamental","pubTime":"2026-05-29 02:52","pubTimestamp":1779994320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HCWB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 28, 2026 14:52 ET (18:52 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCWB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638173632","title":"HCW Biologics CEO buys $160K in common stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2638173632","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638173632?lang=en_us&edition=fundamental","pubTime":"2026-05-28 07:30","pubTimestamp":1779924612,"startTime":"0","endTime":"0","summary":"In a regulatory filing, HCW Biologics (HCWB) disclosed at its CEO Hing bought 113,879 shares of common stock on May 22nd in a total transaction siz...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hcw-biologics-ceo-buys-160k-in-common-stock-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hcw-biologics-ceo-buys-160k-in-common-stock-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","HCWB","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638632523","title":"HCW Biologics CEO Hing C. Wong acquires 113,879 common shares worth $160,499","url":"https://stock-news.laohu8.com/highlight/detail?id=2638632523","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638632523?lang=en_us&edition=fundamental","pubTime":"2026-05-28 07:27","pubTimestamp":1779924430,"startTime":"0","endTime":"0","summary":"HCW Biologics CEO Hing C. Wong bought 113,879 common shares in a private placement at USD 1.41 each.He also bought 113,879 common stock purchase warrants with a USD 1.28 exercise price, expiring Nov. 22, 2031.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCW Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDLH42rl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"HCW Biologics CEO Hing C. Wong acquires 113,879 common shares worth $160,499","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCWB","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638325116","title":"HCW Biologics director Scott T. Garrett reports purchase of 177,936 shares for $249,501.12","url":"https://stock-news.laohu8.com/highlight/detail?id=2638325116","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638325116?lang=en_us&edition=fundamental","pubTime":"2026-05-28 07:25","pubTimestamp":1779924352,"startTime":"0","endTime":"0","summary":"HCW Biologics director Scott T. Garrett reported a private-placement purchase of 177,936 common shares at $1.41 each.Indirect common stock holdings rose to 203,441 shares, held through an LLC.The filing also shows the LLC bought 177,936 common stock purchase warrants with a $1.28 exercise price, lifting warrant holdings to 180,628.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCW Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL9KHhwD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","HCWB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638632591","title":"HCW Biologics CFO Rebecca Byam acquires 14,235 shares for $19,998.68","url":"https://stock-news.laohu8.com/highlight/detail?id=2638632591","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638632591?lang=en_us&edition=fundamental","pubTime":"2026-05-28 07:24","pubTimestamp":1779924252,"startTime":"0","endTime":"0","summary":"HCW Biologics CFO Rebecca Byam bought 14,235 common shares in a private placement at USD 1.41 per share.Her direct holdings rose to 57,245 shares following the purchase.She also bought 14,235 common stock purchase warrants with a USD 1.28 exercise price, expiring Nov. 22, 2031.Warrant holdings increased to 18,466 following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCW Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL9LZ0cf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"HCW Biologics CFO Rebecca Byam acquires 14,235 shares for $19,998.68","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","HCWB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638688576","title":"HCW Biologics Reclaims Key Cell Therapy License Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2638688576","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638688576?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:38","pubTimestamp":1779885498,"startTime":"0","endTime":"0","summary":"HCW Biologics ( ($HCWB) ) has shared an announcement. On May 27, 2026, HCW Biologics announced that it had exercised its option, effective May 21, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hcw-biologics-reclaims-key-cell-therapy-license-rights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hcw-biologics-reclaims-key-cell-therapy-license-rights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","HCWB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638550781","title":"HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents From Wugen","url":"https://stock-news.laohu8.com/highlight/detail?id=2638550781","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638550781?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:46","pubTimestamp":1779882394,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nFWN4240K1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","HCWB","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638507841","title":"HCW Biologics Inc - Buys Rights for No Cost and Retains 2.2 Mln Wugen Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2638507841","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638507841?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:46","pubTimestamp":1779882394,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nFWN4240K1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HCWB","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638507853","title":"HCW Biologics regains full ex vivo rights to HCW9206, HCW9201 from Wugen","url":"https://stock-news.laohu8.com/highlight/detail?id=2638507853","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638507853?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:45","pubTimestamp":1779882320,"startTime":"0","endTime":"0","summary":"HCW Biologics exercised an option to regain full ex vivo rights to HCW9206 and HCW9201 from Wugen.Transaction carried no cost to HCW; it kept a nonrefundable upfront fee that included 2,200,000 Wugen common shares.Move repositions the company to commercialize the reagents for CAR-T and NK-cell therapy manufacturing through partners.HCW cited published data indicating HCW9206 could improve CAR-T manufacturing efficiency, enrich T-memory stem cells, reduce costs.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL9pQKmv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","BK4139","LU0314104364.USD","IE00BN0W2W23.USD","LU2210150020.SGD","IE00BKPKM429.USD","LU2095319765.USD","SG9999014013.SGD","IE00BN0W2V16.EUR","BK4588","LU2210149790.SGD","BK4585","HCWB","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014021.USD","IE00BGHQF748.EUR","BK4539","IE00BN0W2T93.GBP","NDAQ","BK4112","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638800507","title":"HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen","url":"https://stock-news.laohu8.com/highlight/detail?id=2638800507","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638800507?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:45","pubTimestamp":1779882300,"startTime":"0","endTime":"0","summary":"Positions the Company to participate in fast-growing, multi-billion-dollar CAR-T immunotherapy market Recently published data suggest that HCW9206 may reduce CAR-T production costs and improve therape","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/27/3301835/0/en/HCW-Biologics-Exercised-Option-to-Regain-Full-Rights-for-Two-Commercial-Ready-Reagents-from-Wugen.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4022","HCWB","BK4539","BK4230","CAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637631645","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2637631645","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637631645?lang=en_us&edition=fundamental","pubTime":"2026-05-22 19:18","pubTimestamp":1779448694,"startTime":"0","endTime":"0","summary":"PicoCELA  shares were up 172% in Friday premarket activity, extending Thursday's 60% rally.Leifras  stock was 113% higher after the company agreed to acquire Tokai Sports.Akari Therapeutics  shares were up 64% after the company reported positive preclinical data for its AKTX-101 investigational drug candidate.MetaVia  stock was 40% higher following a muted session.HCW Biologics  shares were up 25% after the company priced a private securities offering.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4204","LFS","AKTX","BK4539","HCWB","PCLA","AKTS","BK4020","LFS.AU","BK7093","MTVA","BK4007","BK4139","BK4148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637368191","title":"HCW Biologics Raises $4M in Private Placement Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2637368191","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637368191?lang=en_us&edition=fundamental","pubTime":"2026-05-22 07:13","pubTimestamp":1779405194,"startTime":"0","endTime":"0","summary":"HCW Biologics ( ($HCWB) ) has provided an announcement. On May 21, 2026, HCW Biologics Inc. entered into a private securities purchase agreement wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hcw-biologics-raises-4m-in-private-placement-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hcw-biologics-raises-4m-in-private-placement-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","HCWB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637935946","title":"3 Penny Stocks to Watch Now, 5/21/26","url":"https://stock-news.laohu8.com/highlight/detail?id=2637935946","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637935946?lang=en_us&edition=fundamental","pubTime":"2026-05-22 03:20","pubTimestamp":1779391255,"startTime":"0","endTime":"0","summary":"HCW Biologics ($HCWB), MetaVia ($MTVA), and Silexion Therapeutics ($SLXN) are the three penny stocks to watch on May 21, according to TipRanks’ Pen...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/3-penny-stocks-to-watch-now-5-21-26?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/3-penny-stocks-to-watch-now-5-21-26?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCWB","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637352681","title":"Why HCW Biologics Stock Is Surging On Thursday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2637352681","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637352681?lang=en_us&edition=fundamental","pubTime":"2026-05-22 02:58","pubTimestamp":1779389880,"startTime":"0","endTime":"0","summary":"HCW Biologics Inc. (NASDAQ:HCWB) stock is rallying after securing a $4 million private placement to fund its clinical pipeline. Read the full market breakdown.","market":"us","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=260,dpr=2,format=auto,quality=85/files/images/story/2026/05/21/Growing-Stock-Market-Chart-With-Candlest_2.jpeg","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=260,dpr=2,format=auto,quality=85/files/images/story/2026/05/21/Growing-Stock-Market-Chart-With-Candlest_2.jpeg"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/05/52729890/why-hcw-biologics-stock-is-surging-on-thursday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/05/52729890/why-hcw-biologics-stock-is-surging-on-thursday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4139","SMA","BK4217","HCWB","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637135844","title":"BRIEF-HCW Biologics Prices Private Placement Of 2.8 Mln Units At $1.405 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2637135844","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637135844?lang=en_us&edition=fundamental","pubTime":"2026-05-22 00:16","pubTimestamp":1779380170,"startTime":"0","endTime":"0","summary":"BRIEF-HCW Biologics Prices Private Placement Of 2.8 Mln Units At $1.405 Per UnitMay 21  - HCW Biologics Inc HCWB.O:HCW BIOLOGICS INC. ANNOUNCES PRICING OF APPROXIMATELY $4.0 MILLION PRIVATE PLACEMENT OFFERING AT-THE-MARKET UNDER NASDAQ RULESHCW BIOLOGICS INC - PRICES PRIVATE PLACEMENT OF 2,846,975 UNITS AT $1.405 PER UNIT ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"39601f38409b64cfc96e058ac46dfed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA4KRNYF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCWB","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637334836","title":"HCW Biologics prices USD 4 million private placement at USD 1.41 per unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2637334836","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637334836?lang=en_us&edition=fundamental","pubTime":"2026-05-21 21:53","pubTimestamp":1779371609,"startTime":"0","endTime":"0","summary":"HCW Biologics priced a private placement of 2,846,975 units at USD 1.41 per unit, for gross proceeds of about USD 4 million.Each unit includes one common share or a pre-funded warrant, plus one warrant to buy one common share at an exercise price of USD 1.28; the warrants are exercisable immediately, expire in 5.5 years.Proceeds are earmarked for clinical and preclinical development programs, general corporate purposes, debt repayment, and settlements.HCW Biologics agreed to file a resale registration statement on Form S-1 within 60 days of closing.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"39601f38409b64cfc96e058ac46dfed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL4X5vSG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BN0W2T93.GBP","BK4112","IE00BKPKM429.USD","BK4588","HCWB","IE00BGHQF748.EUR","SG9999014039.USD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","SG9999014013.SGD","BK4585","LU2210149790.SGD","SG9999014005.SGD","SG9999014021.USD","LU0314104364.USD","BK4139","NDAQ","BK4539","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637334882","title":"HCW Biologics Inc. Announces Pricing of Approximately $4.0 Million Private Placement Offering at-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2637334882","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637334882?lang=en_us&edition=fundamental","pubTime":"2026-05-21 21:53","pubTimestamp":1779371585,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"39601f38409b64cfc96e058ac46dfed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA4KRNYF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","HCWB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637334833","title":"HCW Biologics Inc - Prices Private Placement of 2,846,975 Units at $1.405 per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2637334833","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637334833?lang=en_us&edition=fundamental","pubTime":"2026-05-21 21:53","pubTimestamp":1779371585,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"39601f38409b64cfc96e058ac46dfed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA4KRNYF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","HCWB","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hcwbiologics.com;investors.hcwbiologics.com","stockEarnings":[{"period":"1week","weight":-0.2837},{"period":"1month","weight":3.5796},{"period":"3month","weight":2.1364},{"period":"6month","weight":0.0049},{"period":"1year","weight":-0.7322},{"period":"ytd","weight":1.1327}],"compareEarnings":[{"period":"1week","weight":0.0173},{"period":"1month","weight":0.0526},{"period":"3month","weight":0.115},{"period":"6month","weight":0.1092},{"period":"1year","weight":0.287},{"period":"ytd","weight":0.1124}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201, a cell-based therapy that is in Phase I clinical trials for the treatment of patients with relapsed/refractory acute myelogenous leukemia; and HCW9206, an injectable immunotherapeutic to use as adjuvant for adoptive cell therapy in cancer treatment. The company was incorporated in 2018 and is headquartered in Miramar, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.07168},{"month":2,"riseRate":0.6,"avgChangeRate":0.016626},{"month":3,"riseRate":0.4,"avgChangeRate":-0.075342},{"month":4,"riseRate":0.4,"avgChangeRate":-0.059982},{"month":5,"riseRate":0.4,"avgChangeRate":0.568693},{"month":6,"riseRate":0.6,"avgChangeRate":-0.058757},{"month":7,"riseRate":0.5,"avgChangeRate":0.007222},{"month":8,"riseRate":0.4,"avgChangeRate":-0.025444},{"month":9,"riseRate":0.4,"avgChangeRate":-0.08752},{"month":10,"riseRate":0.4,"avgChangeRate":0.021722},{"month":11,"riseRate":0.2,"avgChangeRate":-0.225966},{"month":12,"riseRate":0.2,"avgChangeRate":-0.149456}],"exchange":"NASDAQ","name":"HCW Biologics Inc.","nameEN":"HCW Biologics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HCW Biologics Inc.(HCWB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest HCW Biologics Inc.(HCWB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"HCW Biologics Inc.,HCWB,HCW Biologics Inc.股票,HCW Biologics Inc.股票老虎,HCW Biologics Inc.股票老虎国际,HCW Biologics Inc.行情,HCW Biologics Inc.股票行情,HCW Biologics Inc.股价,HCW Biologics Inc.股市,HCW Biologics Inc.股票价格,HCW Biologics Inc.股票交易,HCW Biologics Inc.股票购买,HCW Biologics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HCW Biologics Inc.(HCWB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest HCW Biologics Inc.(HCWB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction